Harrow Health, Inc. (HROW) financial statements and ratios from SEC XBRL: revenue $0.3B (TTM), net margin -1.9%, revenue growth -7.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $272.30M |
| Revenue (TTM) | $0.3B |
| Net Margin | -1.9% |
| Operating Margin (TTM) | 7.3% |
| Net Debt / EBITDA | 9.5 |
| Revenue Growth (YoY) | -7.6% |
| EPS Growth (YoY) | 48.0% |
| FCF Growth (YoY) | -147.1% |
| EV / EBITDA | 80.3 |
| Price / Book | 53.84 |
| Price / Sales | 5.68 |
| FCF Yield | 0.9% |
| Altman Z-Score | 3.37 (safe) |
| Piotroski F-Score | 6/9 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
HROW overview · HROW earnings · HROW KPIs · HROW documents · HROW ownership · HROW peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.